J&J psoriasis drug posts mixed results in trial
28177
Johnson & Johnson  said on Wednesday its new type of treatment for psoriasis was highly effective in a mid-stage trial, but was linked to an increased risk of serious adverse events, including heart attacks.
251744
Johnson & Johnson JNJ.N has sued   Boston Scientific Corp.BSX.N and Abbott Laboratories Inc.   ABT.N, seeking at least $5.5 billion in damages related to   J&J's failed bid for medical device maker Guidant Corp.
596071
ATLANTIC CITY, New Jersey  - A New Jersey jury found on Friday that Merck & Co.  failed to provide adequate warnings about health risks tied to its withdrawn arthritis drug Vioxx in one case, but decided that it gave adequate warning in another in two suits tried simultaneously.
441631
NEW YORK -- Pfizer Inc. yesterday said a major trial will test whether its popular Celebrex arthritis drug increases the risk of heart attacks, as seen with Merck and Co.'s recalled Vioxx pill.
578981
Pfizer Inc. on Monday said a major new  trial will test whether its  popular Celebrex arthritis drug  increases the risk of heart attacks, as seen with Merck and  Co.'s recalled Vioxx pill.
723616
Pfizer Inc. on Monday announced a major clinical trial of its Celebrex arthritis drug to gauge its possible cardiovascular benefits for osteoarthritis patients.
149032
The stock is feeling some pain these days. However, this drugmaker has enough going for it that the illness shouldn&#39;t last. Amid nervousness over the future of Pfizer&#39;s arthritis pain treatment Celebrex and
716
Johnson & Johnson JNJ.N on Tuesday  said its third-quarter profit rose almost 14 percent on higher  sales of prescription drugs, but U.S. sales of medical devices  slipped on competition from a rival heart device.
528016
Pfizer Inc. on Friday said two clinical trials showed patients taking its anti-inflammatory drug Bextra had a higher risk of cardiovascular events during high-risk coronary bypass surgery.
395582
J&J and Schering revise their agreement over anti-TNF compounds.
357920
Pfizer Inc. on Friday said patients  taking its blockbuster arthritis drug Celebrex in a long-term  cancer-prevention trial had more than twice the number of fatal  or non-fatal heart attacks as those taking a placebo.
378404
Charges hurt the quarterly results of  Johnson & Johnson, Merck & Co. and Schering-Plough Corp., but  the drugmakers' shares rose as J&J's earnings beat Wall Street  forecasts and Merck sales edged higher despite the withdrawal  of its best-selling Vioxx arthritis drug.
410828
WEDNESDAY, Jan. 16 (HealthDay News) -- The drug etanercept significantly improved psoriasis symptoms in children under 17 with moderate to severe psoriasis, researchers are reporting.
403859
TUESDAY, Oct. 5 (HealthDayNews) -- A trial for what appeared to be a promising new therapy for Parkinson's disease has been halted, although researchers haven't given up hope that the drug will one day prove useful.
550692
NEW YORK - Today at the UBS Global Life Sciences Conference, AtheroGenics was met with pointed skepticism over trial results for its drug, AGI-1067.
501444
The Food and Drug Administration has approved a new drug for multiple sclerosis that in clinical trials got better results than existing drugs in protecting against relapses.
762814
A drug often used to treat rheumatoid arthritis -- methotrexate -- seems to improve a condition known as ankylosing spondylitis, Mexican researchers report.